{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:09:39Z","timestamp":1790266179183,"version":"4.1.0"},"reference-count":30,"publisher":"American Medical Association (AMA)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"<jats:sec id=\"ab-zoi260973-4\">\n                    <jats:title>Importance<\/jats:title>\n                    <jats:p>Repetitive transcranial magnetic stimulation (rTMS) is an established intervention for treatment-resistant depression, but only a minority of patients achieve remission, and characteristics associated with response are lacking. Sum-score analyses of the Hamilton Depression Rating Scale (HDRS) obscures how distinct symptom clusters change over time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260973-5\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To identify distinct longitudinal symptom-cluster response trajectories during dorsolateral prefrontal rTMS and to determine baseline characteristics associated with trajectory membership.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260973-6\">\n                    <jats:title>Design, Setting, and Participants<\/jats:title>\n                    <jats:p>This cohort study used data from the THREE-D randomized clinical trial (conducted from 2013 to 2016 at 3 Canadian academic hospitals), applying group-based multitrajectory modeling to mood, anxiety, insomnia, and somatic symptom cluster scores over 4 weeks of rTMS. Analysis was performed in 2024 to 2026. Participants were adults aged 18 to 65 years with major depressive disorder. Outcome assessors were blinded to treatment allocation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260973-7\">\n                    <jats:title>Exposures<\/jats:title>\n                    <jats:p>Once-daily high-frequency (10 Hz) or intermittent theta-burst rTMS to the left dorsolateral prefrontal cortex for 4 to 6 weeks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260973-8\">\n                    <jats:title>Main Outcomes and Measures<\/jats:title>\n                    <jats:p>Primary outcomes were sum scores of 4 previously validated HDRS-17 symptom clusters. Trajectories were derived using group-based multitrajectory modeling; baseline characteristics associated with membership were examined with weighted multinomial logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260973-9\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Of 414 randomized participants, 26 were excluded, leaving 388 in the analytic cohort (mean [SD] age, 42.33 [11.48] years; 229 female [59.02%]). Four trajectory groups were identified: optimal response (119 participants [30.67%]); partial response, high anxiety (128 participants [32.99%]); partial response, low anxiety (91 participants [23.45%]); and minimal response (50 participants [12.88%]). Final response and remission rates ranged from 83.48% and 65.22%, respectively, in the optimal response group to 0% in the minimal response group. Compared with the partial response, high anxiety reference, minimal response was associated with younger age (odds ratio [OR], 0.95; 95% CI, 0.92-0.99;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.01), benzodiazepine use (OR, 2.73; 95% CI, 1.24-6.05;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009=\u2009.01), lower baseline anxiety (OR, 0.73; 95% CI, 0.60-0.89;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001), and higher baseline mood symptoms (OR, 1.35; 95% CI, 1.13-1.61;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2009&amp;amp;lt;\u2009.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"ab-zoi260973-10\">\n                    <jats:title>Conclusions and Relevance<\/jats:title>\n                    <jats:p>In this cohort study of adults with treatment-resistant depression, 4 longitudinal symptom-cluster response trajectories were identified, with marked divergence in clinical outcomes. Baseline anxiety severity and benzodiazepine use were associated with trajectory membership and may inform personalized treatment planning, although prospective studies are required.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2026.36032","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:31:51Z","timestamp":1790263911000},"page":"e2636032","source":"Crossref","is-referenced-by-count":0,"title":["Dorsolateral Prefrontal rTMS Symptom Cluster Response Trajectories for Depression"],"prefix":"10.1001","volume":"9","author":[{"given":"Tyler S.","family":"Kaster","sequence":"first","affiliation":[{"name":"Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Psychology, Shanghai Jiao Tong University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Downar","sequence":"additional","affiliation":[{"name":"Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Institute of Medical Science, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidel","family":"Vila-Rodriguez","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of British Columbia, Vancouver, British Columbia, Canada"},{"name":"Non-Invasive Neurostimulation Therapies (NINET) Laboratory, University of British Columbia, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle A.","family":"Baribeau","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Holland Bloorview Kids Rehabilitation Hospital, Bloorview Research Institute, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Thorpe","sequence":"additional","affiliation":[{"name":"Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zafiris J.","family":"Daskalakis","sequence":"additional","affiliation":[{"name":"Department of Psychiatry, San Diego Health, University of California, San Diego"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao-Gan","family":"Yan","sequence":"additional","affiliation":[{"name":"Department of Psychological and Cognitive Sciences, Tsinghua University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel M.","family":"Blumberger","sequence":"additional","affiliation":[{"name":"Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"},{"name":"Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada"},{"name":"Campbell Family Mental Health Research Institute, Centre for Addiction and Mental Health, Toronto, Ontario, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2026,9,24]]},"reference":[{"issue":"1","key":"zoi260973r1","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/YCO.0b013e32835ab46d","article-title":"The expanding evidence base for rTMS treatment of depression.","volume":"26","author":"George","year":"2013","journal-title":"Curr Opin Psychiatry"},{"issue":"3","key":"zoi260973r2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.brs.2016.03.010","article-title":"The Clinical TMS Society Consensus Review and Treatment Recommendations for TMS Therapy for Major Depressive Disorder.","volume":"9","author":"Perera","year":"2016","journal-title":"Brain Stimul"},{"issue":"9","key":"zoi260973r3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1176\/appi.ajp.20230556","article-title":"rTMS as a next step in antidepressant nonresponders: a randomized comparison with current antidepressant treatment approaches.","volume":"181","author":"Dalhuisen","year":"2024","journal-title":"Am J Psychiatry"},{"issue":"4","key":"zoi260973r4","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1038\/s41386-024-02007-w","article-title":"Extended course accelerated intermittent theta burst stimulation as a substitute for depressed patients needing electroconvulsive therapy.","volume":"50","author":"Goodman","year":"2025","journal-title":"Neuropsychopharmacology"},{"issue":"8","key":"zoi260973r5","doi-asserted-by":"publisher","first-page":"1217","DOI":"10.1038\/s41386-023-01575-7","article-title":"The effects of D-cycloserine on corticospinal excitability after repeated spaced intermittent theta-burst transcranial magnetic stimulation: a randomized controlled trial in healthy individuals.","volume":"48","author":"Wrightson","year":"2023","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"zoi260973r6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.biopsych.2012.04.028","article-title":"Efficacy of transcranial magnetic stimulation targets for depression is related to intrinsic functional connectivity with the subgenual cingulate.","volume":"72","author":"Fox","year":"2012","journal-title":"Biol Psychiatry"},{"issue":"5","key":"zoi260973r7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1176\/appi.ajp.2019.19090915","article-title":"Distinct symptom-specific treatment targets for circuit-based neuromodulation.","volume":"177","author":"Siddiqi","year":"2020","journal-title":"Am J Psychiatry"},{"issue":"8","key":"zoi260973r8","doi-asserted-by":"publisher","first-page":"4525","DOI":"10.1038\/s41380-026-03535-1","article-title":"Circuit-targeted modulation of anxiety symptoms in individuals with major depression: a randomized head-to-head TMS trial.","volume":"31","author":"Taylor","year":"2026","journal-title":"Mol Psychiatry"},{"key":"zoi260973r9","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s12916-015-0325-4","article-title":"Depression sum-scores don\u2019t add up: why analyzing specific depression symptoms is essential.","volume":"13","author":"Fried","year":"2015","journal-title":"BMC Med"},{"issue":"1","key":"zoi260973r10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/jnnp.23.1.56","article-title":"A rating scale for depression.","volume":"23","author":"Hamilton","year":"1960","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"11","key":"zoi260973r11","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1037\/pas0000275","article-title":"Measuring depression over time . . . Or not? Lack of unidimensionality and longitudinal measurement invariance in four common rating scales of depression.","volume":"28","author":"Fried","year":"2016","journal-title":"Psychol Assess"},{"issue":"12","key":"zoi260973r12","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1176\/appi.ajp.161.12.2163","article-title":"The Hamilton Depression Rating Scale: has the gold standard become a lead weight?","volume":"161","author":"Bagby","year":"2004","journal-title":"Am J Psychiatry"},{"key":"zoi260973r13","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101765","article-title":"Differential symptom cluster responses to repetitive transcranial magnetic stimulation treatment in depression.","volume":"55","author":"Kaster","year":"2022","journal-title":"EClinicalMedicine"},{"key":"zoi260973r14","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1146\/annurev.clinpsy.121208.131413","article-title":"Group-based trajectory modeling in clinical research.","volume":"6","author":"Nagin","year":"2010","journal-title":"Annu Rev Clin Psychol"},{"issue":"5","key":"zoi260973r15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1176\/appi.ajp.2018.18091096","article-title":"Trajectories of response to dorsolateral prefrontal rTMS in major depression: a THREE-D study.","volume":"176","author":"Kaster","year":"2019","journal-title":"Am J Psychiatry"},{"issue":"3","key":"zoi260973r16","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.brs.2024.04.010","article-title":"Depressive symptom trajectories with prolonged rTMS treatment.","volume":"17","author":"Chen","year":"2024","journal-title":"Brain Stimul"},{"issue":"3","key":"zoi260973r17","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.brs.2020.02.021","article-title":"Depressive symptom trajectories associated with standard and accelerated rTMS.","volume":"13","author":"Kaster","year":"2020","journal-title":"Brain Stimul"},{"issue":"7","key":"zoi260973r18","doi-asserted-by":"publisher","first-page":"2015","DOI":"10.1177\/0962280216673085","article-title":"Group-based multi-trajectory modeling.","volume":"27","author":"Nagin","year":"2018","journal-title":"Stat Methods Med Res"},{"issue":"10131","key":"zoi260973r19","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1016\/S0140-6736(18)30295-2","article-title":"Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.","volume":"391","author":"Blumberger","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"zoi260973r20","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1080\/10705511.2016.1247646","article-title":"The GRoLTS-checklist: guidelines for reporting on latent trajectory studies.","volume":"24","author":"Van De Schoot","year":"2017","journal-title":"Struct Equ Modeling"},{"issue":"11","key":"zoi260973r22","doi-asserted-by":"publisher","first-page":"1208","DOI":"10.1016\/j.biopsych.2007.01.018","article-title":"Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial.","volume":"62","author":"O\u2019Reardon","year":"2007","journal-title":"Biol Psychiatry"},{"issue":"4","key":"zoi260973r23","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1177\/0049124113503141","article-title":"A note on a Stata plugin for estimating group-based trajectory models.","volume":"42","author":"Jones","year":"2013","journal-title":"Sociol Methods Res"},{"issue":"430","key":"zoi260973r24","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1080\/01621459.1995.10476572","article-title":"Bayes factors.","volume":"90","author":"Kass","year":"1995","journal-title":"J Am Stat Assoc"},{"key":"zoi260973r26","first-page":"10","article-title":"The definition and meaning of treatment-resistant depression.","volume":"62","author":"Sackeim","year":"2001","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"zoi260973r27","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1016\/j.brs.2021.09.003","article-title":"A randomized sham controlled comparison of once vs twice-daily intermittent theta burst stimulation in depression: a Canadian rTMS treatment and biomarker network in depression (CARTBIND) study.","volume":"14","author":"Blumberger","year":"2021","journal-title":"Brain Stimul"},{"issue":"8030","key":"zoi260973r28","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1038\/s41586-024-07805-2","article-title":"Frontostriatal salience network expansion in individuals in depression.","volume":"633","author":"Lynch","year":"2024","journal-title":"Nature"},{"issue":"18","key":"zoi260973r29","doi-asserted-by":"publisher","first-page":"9078","DOI":"10.1073\/pnas.1900390116","article-title":"Reduced default mode network functional connectivity in patients with recurrent major depressive disorder.","volume":"116","author":"Yan","year":"2019","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"zoi260973r30","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.biopsych.2023.11.011","article-title":"Targeting symptom-specific networks with transcranial magnetic stimulation.","volume":"95","author":"Siddiqi","year":"2024","journal-title":"Biol Psychiatry"},{"key":"zoi260973r25","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2013"},{"key":"zoi260973r21","unstructured":"Kaster? T, Downar? J, Vila-Rodriguez? F, . Depressive symptom cluster multi-group trajectories with repetitive transcranial magnetic stimulation. Open Science Foundation. November 29, 2024. Accessed August 19, 2026. https:\/\/osf.io\/3mn8u"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2854431\/kaster_2026_oi_260973_1789583131.84567.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:31:58Z","timestamp":1790263918000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2854431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2026.36032","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}